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Background: We evaluated risk factors associated with chronic headache (CH) such as age, gender, smoking,
frequent drinking of alcoholic beverages (drinking), obesity, education and frequent intake of acute pain drugs
to test their usefulness in clinical differentiation between chronic migraine (CM) and chronic tension-type
headache (CTTH).
Methods: We used baseline data from the population-based German Headache Consortium Study including
9,944 participants aged 18–65 years, screened 2003–2005, using validated questionnaires. CM and CTTH were
defined according to IHS criteria. Multinominal logistic regression analyses were used to investigate the
association of CM or CTTH with risk factors by estimating odds ratios (OR) and 95% confidence intervals (95%CI).
Results: The prevalence of CH was 2.6% (N = 255, mean age 46 ± 14.1 years, 65.1% women), CM 1.1% (N = 108,
45 ± 12.9 years, 73.1%), CTTH 0.5% (N = 50, 49 ± 13.9 years, 48.0%). Participants with CM compared to CTTH were more
likely to be female (OR: 2.34, 95%CI: 1.00-5.49) and less likely to drink alcohol (0.31, 0.09-1.04). By trend they seemed
more likely to smoke (1.81, 0.76-4.34), to be obese (1.85, 0.54-6.27), to report frequent intake of acute pain drugs
(1.68, 0.73-3.88) and less likely to be low educated (0.72, 0.27-1.97).
Conclusions: We concluded that the careful assessment of different risk factors might aid in the clinical differentiation
between CM and CTTH.
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Migraine and tension-type headache (TTH) are the most
common primary headache disorders affecting up to
80% of the general population [1]. Phenotypically they
are different. Migraine is characterized by unilateral se-
vere pulsating headache accompanied by typical auto-
nomic symptoms such as nausea, vomiting, photo- and
phonophobia. In contrast, TTH is characterized by mild
to moderate headache intensity and of dull, tightening
character without autonomic symptoms. Diagnostic cri-
teria are simple and clinically useful in cases with epi-
sodic headache but often fail to adequately classify
patients with chronic headache that suffer from daily or* Correspondence: sara.schramm@uk-essen.de
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in any medium, provided the original work is pnearly daily headaches without clearly distinguishable or
overlapping clinical features into migraine or tension-
type headache. When both conditions coexist in the same
patient this problem becomes even more evident. In popu-
lation based studies in which diagnoses are based on self-
reported headache features this unclear distinction might
lead to skewered data and result in misinterpretation.
The prevalence of headache subtypes of our study
population based on the German Headache Consortium
(GHC) was published previously [2]. Due to its large
sample size the population of the GHC provides a good
opportunity to investigate respondents with pure CM
and compares them with pure CTTH in order to investi-
gate differences in possible risk factors such as age, gen-
der, smoking, daily or almost daily drinking of alcoholic
beverages (drinking), obesity, education and frequent in-
take of acute pain drugs that might favour the develop-
ment of one or the other.is an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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Study design and study population
The study of the GHC was described in detail elsewhere
[2]. Briefly, the GHC study is a large population-based
cohort study supported by the German Federal Ministry
of Education and Research. The study was approved by
the ethics committee of the University of Duisburg-Essen,
Germany. Informed written consent was obtained from all
subjects. 18,000 subjects between the age of 18–65 years
with German citizenship were randomly selected via pos-
tal mail from statutory lists of residence drawn from
three cities in Germany: Essen (585,481 residents, large
town), Muenster (272,890 residents, medium-sized town),
Sigmaringen (16,501 residents, small town and rural area).
We obtained information per mailed questionnaire or
telephone interview from 9,944 participants. The ques-
tionnaire is based on the ICHD-2 classification criteria of
the International Headache Society [3]. A detailed descrip-
tion and validation of the headache-screening question-
naire was published previously [4,5]. In summary, the
questionnaire included questions on personal data, inquiry
on socio-economic status based primarily on education to
avoid direct questions about income, and medical inquiry
to diagnose migraine and TTH according to the ICHD-2
classification criteria as well as questions to ascertain the
number of days associated with headache and use of acute
or preventive medication.
Analysis
Results are based on the baseline cross sectional analyses
of the GHC of 9,944 participants. Primary outcomes were
chronic migraine (CM), episodic migraine (EM), chronic
tension-type headache (CTTH), episodic tension-type
headache (ETTH) and no headache (NH). Migraine was
diagnosed if respondents reported headache in the previ-
ous year and met ICHD-2 criteria for definite or probable
migraine and had either ≥15 headache-days/month (CM)
or <15 headache-days/month (EM). TTH was diagnosed
if respondents reported headache in the previous year
and met ICHD-2 criteria for definite or probable TTH
and had either ≥15 headache-days/month (CTTH) or
<15 headache-days/month (ETTH).
We investigated the following risk factors: age, gender,
smoking, drinking, obesity, education and frequent in-
take of acute pain drugs. Mean age with standard devi-
ation and gender distribution was calculated for each
subgroup. Number of cases and percentages were pro-
vided of smoking (yes vs. no), drinking (daily vs. not daily
drinking), obesity (Body Mass Index (BMI) >30 kg/m2 vs.
BMI ≤30 kg/m2), education (low vs. high) and frequent in-
take of acute pain drugs (yes vs. no). Smoking (yes) was
defined as current smoking and smoking (no) was defined
as never or past smoking. Drinking (yes) was defined as
daily or almost daily drinking of alcoholic beverages anddrinking (no) was defined as no or casual drinking of alco-
holic beverages. High education was defined as com-
pletion of secondary (high) school graduation with
qualification for University or University diploma and low
as any other response. Frequent intake of acute pain drugs
was defined as intake of acute pain drugs (including any
pain and migraine drugs) on ≥15 days/month.
Descriptive statistics were utilized to characterize the
respondent population by headache subtype. Crude odds
ratios (OR) and 95% confidence intervals (95%CI) were
calculated for each risk factor by headache subtype vs.
no headache. Multivariable logistic regression analyses
were used to test the association of age, gender, smok-
ing, drinking, obesity and education within headache
subtypes or NH by estimating OR and 95%CI (model 1).
Frequent intake of acute pain drugs was added to model 1
(model 2). All statistics were completed in SAS, version
9.2 (Statistical Analysis Systems Corp., Cary, NC, USA).
Results
Of 9,944 respondents at baseline 2,952 participants were
excluded: 278 of them did not report headache frequency,
31 did not report the headache type, 1,224 had concomi-
tant migraine and TTH and 1,419 had unclassifiable head-
aches. In 9,635 cases, data about headache subtype were
complete. Figure 1 shows the flow chart of our study
population and Table 1 shows the characteristics of our
study population. We identified 255 participants reporting
headache on at least 15 days/month (CH) resulting in a
prevalence of 2.6% (95%CI: 2.3-3, mean age 46 ± 14.1
years, 65.1% women). The prevalence of CM was 1.1%
(95%CI: 0.9-1.3, N = 108, mean age 45 ± 12.9 years, 73.1%
women), of CTTH it was 0.5% (95%CI: 0.4-0.7, N = 50,
mean age 49 ± 13.9 years, 48.0% women). In 74 partici-
pants we diagnosed chronic migraine with concomitant
chronic TTH (CM + CTTH) and in 23 respondents the
phenotype of chronic headache was unclassifiable. Overall
prevalence of episodic headache was 55.5% (95%CI: 54.5-
56.5, N = 5350, mean age 40 ± 12.4 years, 61.6% woman).
The prevalence of EM was 16.6% (95%CI: 15.9-17.4, N =
1601, mean age 40 ± 11.8 years, 70.9% women), and of
ETTH it was 12.5% (95%CI: 11.8-13.1, N = 1203, mean
age 41 ± 12.6 years, 58.0% women). Episodic migraine
with concomitant TTH (EM + ETTH) was diagnosed in
1150 participants, unclassifiable episodic headache in 1396
respondents. No headache was reported by 41.8% (95%CI:
40.8-42.8, N = 4030, mean age 47 ± 12.8 years, 40.2%
women).
On average respondents of both groups, CM and CTTH
were older than those in the episodic headache groups.
CM group comprised predominantly of females and in
CTTH group the gender distribution was equal.
Tables 2, 3 and 4 show the results of ORs and 95%CIs
of possible risk factors for CM vs. CTTH (Table 2) and
Figure 1 Flow chart of the study population. Legend: CH = chronic headache, CM/EM = chronic/episodic migraine, CTTH/ETTH = chronic/
episodic tension-type headache, CM+CTTH / EM+ETTH = chronic / episodic migraine with concomitant tension-type headache.
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vs. EM, and CTTH vs. ETTH (Table 4).
Participants with CM compared to CTTH were more
likely to be female (OR: 2.34, 95%CI: 1.00-5.49) and less
likely to drink (OR: 0.31, 95%CI: 0.09-1.04). By trend par-
ticipants with CM were more likely to smoke (OR: 1.81,
95%CI: 0.76-4.34), to be obese (OR: 1.85, 95%CI: 0.54-
6.27), to report frequent intake of acute pain drugs (OR:
1.68, 95%CI: 0.73-3.88) and less likely to be low educated
(OR: 0.72, 95%CI: 0.27-1.97) compared to CTTH (Table 2).
Participants with CM compared to NH were more
likely to be female (OR: 2.64, 95%CI: 1.57-4.45), to
smoke (OR: 1.77, 95%CI: 1.07-2.94) and to report fre-
quent intake of acute pain drugs (OR: 59.75, 95%CI:
34.74-102.77) and by trend they are less likely to drink
(OR: 0.64, 95%CI: 0.25-1.64). Participants with CTTH
compared to NH were more likely to drink (OR: 2.28,
95%CI: 1.06-4.93) and to report frequent intake of acute
pain drugs (OR: 30.03, 95%CI: 14.38-62.71) and by trend
they were more likely to be female (OR: 1.11, 95%CI:
0.58-2.13), to be low educated (OR: 1.17, 95%CI: 0.54-
2.53) and less likely to be obese (OR: 0.42, 95%CI: 0.15-
1.18) (Table 3).
Participants with CM compared to EM were more
likely to be older (OR: 1.04, 95%CI: 1.01-1.06) and to re-
port frequent intake of acute pain drugs (OR: 15.17, 95%
CI: 9.29-24.77) and by trend they were more likely to
smoke (OR: 1.43, 95%CI: 0.88-2.32) and to drink (OR:
1.29, 95%CI: 0.51-3.26). Participant with CTTH com-
pared to ETTH were more likely to be older (OR: 1.04,
95%CI: 1.01-1.07), to drink (OR: 3.08, 95%CI: 1.34-7.09)
and to report frequent intake of acute pain drugs (OR:
20.47, 95%CI: 8.84-47.36) and by trend they were more
likely to be male (OR: 0.67, 95%CI: 0.34-1.35) and to be
low educated (OR: 1.64, 95%CI: 0.75-3.57) (Table 4).Adjusting for frequent intake of acute pain drugs sig-
nificantly changed the models, whereby frequent intake
of acute pain drugs became the strongest risk factor.
Discussion
In this study we aimed to identify specific risk factors
for the development of chronic migraine and chronic
tension-type headache in order to support the clinical
distinction between these two most common primary
headache disorders on the basis of their respective epi-
demiological risk factor profile. The prevalence of mi-
graine in our study was 17.7% (1.1% CM+ 16.6% EM).
This is comparable to previous studies from Europe and
the USA [6-10] which reported a prevalence of 13.2% to
21.3%. Previous data on the prevalence of TTH are more
heterogeneous and differ from 20.7% to more than 63%
[10-13]. In our study the prevalence of TTH was lower
with 13% (0.5% CTTH + 12.5% ETTH). The wide vari-
ation of estimated prevalence in TTH might be due to
different questionnaires used, the improper distinction
between life-time and one-year prevalence and different
age profiles.
Overall the one-year prevalence of chronic headache
in our study was 2.6% (95%CI: 2.3-3). The results were
in line with European and American studies which re-
ported a prevalence of 2.98% to 4.7% [14-19]. In our
study CM was more common and comprised of more
women than CTTH. Compared to other European and
American studies the prevalence of CM with 1.1% (95%
CI: 0.9-1.3) and CTTH with 0.5% (95%CI: 0.4-0.7) in our
study was lower and more men were affected. For CM
the prevalence reported by other European and Ameri-
can studies was 1.4% to 2.4% and 2% to 2.2% for CTTH
[14,15,18,20]. The reported fraction of women was 89%
in CM and 91% in CTTH [14]. Noticeable is, that Scher
Table 1 Characteristics of study population
No headache EM CM ETTH CTTH
N = 4030 N = 1601 N = 108 N = 1203 N = 50
age, years
mean, (SD) 46.7 (12.8) 40.4 (11.8) 45.3 (12.9) 41.1 (12.6) 49.4 (13.9)
min, max 18, 66 5, 66 18, 66 18, 66 19, 65
missing, N 2 1 0 1 0
gender, N (%)
men 2408 (59.8) 466 (29.1) 29 (26.9) 505 (42.0) 26 (52.0)
women 1622 (40.2) 1135 (79.9) 79 (73.1) 698 (58.0) 24 (48.0)
missing 0 0 0 0 0
drinkinga, N (%)
no 3086 (76.6) 1467 (91.6) 97 (89.8) 1069 (89.0) 38 (76.0)
yes 555 (13.8) 106 (6.6) 8 (7.4) 115 (9.5) 11 (22.0)
missing 389 (9.6) 28 (1.8) 3 (2.8) 19 (1.5) 1 (2.0)
smokingb, N (%)
no 2581 (64.0) 1071 (66.9) 62 (57.4) 839 (69.7) 32 (64.0)
yes 1075 (26.7) 513 (32.0) 44 (40.7) 350 (29.1) 17 (34.0)
missing 374 (9.3) 17 (1.1) 2 (1.9) 14 (1.2) 1 (2.0)
educationc, N (%)
high* 1005 (24.9) 548 (34.2) 20 (18.5) 470 (39.1) 12 (24.0)
low 2587 (64.1) 1018 (63.6) 86 (79.6) 715 (59.4) 38 (76.0)
missing 438 (12.1) 35 (2.2) 2 (1.9) 18 (1.5) 0 (0)
BMI, N (%)
< 30 3090 (76.7) 1367 (85.4) 88 (81.5) 1044 (86.8) 43 (86.0)
≥ 30 479 (11.9) 192 (12.0) 19 (17.6) 129 (10.7) 5 (10.0)
missing 461 (11.4) 42 (2.6) 1 (0.9) 30 (2.5) 2 (4.0)
frequent medication intaked, N (%)
yes 74 (1.8) 105 (6.6) 54 (50.0) 33 (2.7) 15 (30.0)
no 3442 (85.4) 1337 (83.5) 41 (38.0) 1056 (87.8) 30 (60.0)
missing 514 (12.8) 159 (9.9) 13 (12.0) 114 (9.5) 5 (10.0)
a Drinking (yes) was defined as daily or almost daily drinking of alcoholic beverage and drinking (no) was defined as no or casual drinking of alcoholic beverage.
b Smoking (yes) was defined as current smoking and smoking (no) was defined as never or past smoking.
c High education was defined as completion high school or University and low as any other response.
d Frequent medication intake was defined as intake of acute pain drugs on ≥15 days per month.
Table 2 Association between possible risk factors and CM vs. CTTH
Crude Model 1a Model 2b
OR 95%CI OR 95%CI OR 95%CI
CM vs. CTTH age 0.98 0.95-1.00 0.98 0.95-1.01 0.99 0.96-1.02
female vs male 2.95 1.47-5.94 2.24 1.02-4.91 2.34 1.00-5.49
smoking vs non-smoking 1.34 0.66-2.70 1.52 0.70-3.30 1.81 0.76-4.34
drinking vs non-drinking 0.29 0.11-0.76 0.38 0.13-1.11 0.31 0.09-1.04
obese vs not obese 1.86 0.65-5.31 2.50 0.78-7.98 1.85 0.54-6.27
low vs high education 1.36 0.60-3.06 1.14 0.46-2.80 0.72 0.27-1.97
frequent vs no frequent medication intake 2.63 1.26-5.53 1.68 0.73-3.88
a model 1: fully adjusted without frequent medication intake.
b model 2: fully adjusted with frequent medication intake.
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Table 3 Association between possible risk factors and CM vs. NH / CTTH vs. NH
Crude Model 1a Model 2b
OR 95%CI OR 95%CI OR 95%CI
CM vs NH age 0.99 0.98-1.01 0.98 0.97-1.00 0.98 0.95-1.00
female vs male 4.04 2.63-6.22 4.25 2.70-6.66 2.64 1.57-4.45
smoking vs non-smoking 1.70 1.15-2.52 1.88 1.25-2.83 1.77 1.07-2.94
drinking vs non-drinking 0.46 0.22-0.95 0.74 0.35-1.57 0.64 0.25-1.64
obese vs not obese 1.39 0.84-2.31 1.72 1.02-2.92 0.85 0.43-1.70
low vs high education 1.67 1.02-2.73 1.48 0.88-2.50 0.85 0.47-1.54
frequent vs no frequent medication intake 61.26 38.41-97.70 59.75 34.74-102.77
CTTH vs NH age 1.02 0.99-1.04 1.02 0.99-1.04 1.00 0.97-1.03
female vs male 1.37 0.78-2.40 1.48 0.82-2.68 1.11 0.58-2.13
smoking vs non-smoking 1.28 0.71-2.31 1.37 0.75-2.51 1.06 0.53-2.10
drinking vs non-drinking 1.61 0.82-3.17 1.67 0.82-3.43 2.28 1.06-4.93
obese vs not obese 0.75 0.30-1.90 0.71 0.27-1.81 0.42 0.15-1.18
low vs high education 1.23 0.64-2.36 1.11 0.56-2.22 1.17 0.54-2.53
frequent vs no frequent medication intake 23.26 12.01-45.05 30.03 14.38-62.71
a model 1: fully adjusted without frequent medication intake.
b model 2: fully adjusted with frequent medication intake.
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prevalence of CM and CTTH in the literature might be
due to the fact, that different definitions for headache
subtypes were used.
Our study demonstrated different risk factors compar-
ing CM and CTTH which may reflect a different neuro-
biology of both conditions. Participants with CM
compared to CTTH were more likely to be female and less
likely to drink alcohol. By trend participants with CM areTable 4 Association between possible risk factors and CM vs.
Crud
OR
CM vs EM age 1.04
female vs male 1.12
smoking vs non-smoking 1.48
drinking vs non-drinking 1.14
obese vs not obese 1.54
low vs high education 2.32
frequent vs no frequent medication intake 16.77
CTTH vs ETTH age 1.06
female vs male 0.67
smoking vs non-smoking 1.27
drinking vs non-drinking 2.69
obese vs not obese 0.94
low vs high education 2.08
frequent vs no frequent medication intake 16.00
a model 1: fully adjusted without frequent medication intake.
b model 2: fully adjusted with frequent medication intake.more likely to smoke, to be obese, to report frequent in-
take of acute pain drugs to treat acute headache attacks
and less likely to be low educated compared to CTTH.
In our study participants with CM drank alcohol less
frequently than individuals without headache or other
investigated headache subgroups. The same was reported
in the literature [21]. It was also reported that consump-
tion of alcoholic beverages aggravates or triggers migraine,
which is a good explanation for this observation [22-24].EM / CTTH vs. ETTH
e Model 1a Model 2b
95%CI OR 95%CI OR 95%CI
1.02-1.05 1.03 1.01-1.05 1.04 1.01-1.06
0.72-1.74 1.09 0.69-1.72 0.98 0.58-1.65
0.99-2.21 1.62 1.06-2.46 1.43 0.88-2.32
0.54-2.41 1.12 0.52-2.42 1.29 0.51-3.26
0.92-2.58 1.40 0.82-2.38 0.99 0.52-1.89
1.41-3.81 1.69 1.00-2.87 0.94 0.53-1.68
10.67-26.35 15.17 9.29-24.77
1.03-1.08 1.05 1.02-1.08 1.04 1.01-1.07
0.38-1.78 0.70 0.38-1.30 0.67 0.34-1.35
0.70-2.32 1.32 0.71-2.45 0.85 0.41-1.77
1.34-5.41 2.10 0.99-4.49 3.08 1.34-7.09
0.37-2.42 0.71 0.27-1.87 0.37 0.12-1.16
1.08-4.03 1.65 0.82-3.31 1.64 0.75-3.57
7.87-32.55 20.47 8.84-47.36
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uted to the role of migraine trigger that alcoholic bever-
ages can exert, but it does not account for the higher use
of alcoholic drinks among CM participants compared to
EM participants in our study population (OR: 1.29, 95%
CI: 0.51-3.26) (Table 4). In theory, CM patients should
avoid alcoholic drinks more than EM patients. Participants
with CTTH were more likely to drink than participants
with CM or NH (CM vs. CTTH: OR: 0.31, 95%CI: 0.09-
1.04, CTTH vs. NH: OR: 2.28, 95%CI: 1.06-4.93). Daily or
almost daily drinking of alcoholic beverages might be a
useful feature in clinical distinction of CM and CTTH.
A higher severity of headaches among smokers than
among non-smokers was reported previously, but cur-
rent data are still insufficient to prove a causal link be-
tween cigarette smoking and worsening headache [25,26].
Otherwise, headache is a known withdrawal syndrome of
nicotine cessation [27]. In our study participants with CM
were more likely to smoke than participants with CTTH
(OR: 1.81, 95%CI: 0.76-4.34). Participants with CM were
also more likely to smoke than participants with EM (OR:
1.43, 95%CI: 0.88-2.32) or NH (OR: 1.77, 95%CI: 1.07-
2.94). Participants with CTTH were not more likely to
smoke than ETTH (OR: 0.85, 95%CI: 0.41-1.77) or NH
(OR: 1.06, 95%CI: 0.53-2.10) in our adjusted model
(model 2).
Obesity was found to be a risk factor for CM in the lit-
erature, although migraine by itself was not more preva-
lent in obese patients. Obesity was also associated with
the frequency and severity of migraine [28], but the
causal link between obesity and migraine remains to be
determined. There are studies that reported an associ-
ation between obesity and CM that did not adjust for
frequent intake of acute pain drugs [29,30]. After
adjusting for frequent intake of acute pain drugs the as-
sociation between CM and obesity compared to NH di-
minished (OR: 0.85; 95%CI: 0.43-1.70). Adjustment for
frequent intake of acute pain drugs changed the model
significantly, and resulted in frequent intake of acute
pain drugs becoming the strongest risk factor for the de-
velopment of CM. However, our data suggests a trend
that participants with CM compared to CTTH were
more likely to be obese (OR: 1.85, 95%CI: 0.54-6.27).
This may hint at a common pathophysiological influence
of obesity and the development of chronic headache in-
dependent of the underlying primary headache disorder.
This association or influence might be pronounced dif-
ferently in different headache conditions and therefore
appears to be stronger in CM compared to CTTH.
An association between low education and CH is fre-
quently discussed in the literature. Studies showed that
the prevalence of CH was highest in the lowest educa-
tion category [18] and subjects with CTTH had less edu-
cation, on average, than subjects with ETTH [20]. Thisis consistent with our results in regard to CTTH and
education. Participants with CTTH are lower educated
than participants with NH (OR: 1.17, 95%CI: 0.54-2.53),
ETTH (OR: 1.64, 95%CI: 0.75-3.57) and also CM (CM
vs. CTTH: OR: 0.72, 95%CI: 0.27-1.97). Regarding CM
reports in the literature are inconsistent [18,31] but gen-
erally describe an association between CM and low edu-
cation after fully adjusting. Crude and in model 1 we
found that participants with CM were more likely to be
low educated compared to NH or EM. However, ad-
justing for frequent intake of acute pain drugs (model 2)
changes the model significantly and we found no associ-
ation between low education and CM (CM vs. NH: OR:
0.85, 95%CI: 0.47-1.54; CM vs. EM: OR: 0.94, 95%CI:
0.53-1.68) any more, whereas frequent intake of acute
pain drugs became the strongest risk factor. Many stud-
ies which describe an association between CM and low
education did not adjust for frequent intake of acute
pain drugs and might have been misinterpreted [29,31].
The role of education for the development of chronic
daily headache needs to be further elucidated in future
research.
A strong association between CH and overuse of acute
pain drugs was demonstrated in many epidemiologic
studies worldwide [14,15,32-35]. Overuse of acute pain
drugs was found in more than half of CH patients in
clinic-based studies. This was confirmed by our data
with 50% of CM and 30% of CTTH reporting frequent
intake of acute pain drugs. It is unknown if frequent in-
take of acute pain drugs is the cause or consequence of
CH. Compared to CTTH there is a trend that partici-
pants with CM were more likely to report frequent in-
take of acute pain drugsn (OR: 1.68, 95%CI: 0.73-3.88).
In summary, we found lower prevalence of CDH, CM
and CTTH and a higher male fraction in our study
population compared to the literature. Furthermore, we
cannot confirm an association between obesity and CM,
as well as low education and CM in the fully adjusted
model. Different smoking, drinking and use of acute
pain drugs habits as well as differences in weight and
gender between CM and CTTH were found.
Strengths of this study are the large representative
population-based sample in three different regions of
Germany and therefore the large number of outcomes.
The power was great enough to test a number of prede-
fined covariates. Another strength is the use of validated
questionnaires that were published prior to the study.
Limitations of our study are the overall response rate
of the survey of 55%, which is satisfactory in comparison
to other large-scale population-based studies in Western
Europe and the US, but selection bias cannot be ex-
cluded. More affected persons tend to participate more
eagerly than non-affected healthy persons and very old
and very young people often do not participate in
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detecting the headache features, recall bias cannot be ex-
cluded. These limitations are not unique to our study.
All large-scale questionnaire-based studies face these
challenges.
Conclusion
In conclusion, our investigation shows that CM and
CTTH have slightly different risk factors that might be
due to their different neurobiology and may help in the
clinical distinction of CH into CM and CTTH. Patients
with CM were more likely to be female, to smoke, to be
obese, and to report frequent intake of acute pain drugs,
while patients with CTTH had a higher intake of alco-
holic beverages and a lower education. Consideration of
these different epidemiological profiles may become an
asset in finding the correct primary headache disorder in
patients presenting with chronic headache and guide ap-
propriate treatment.
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